How to interpret fibroscan result?

Reading File
Finding Sources
Searching PubMed

"transient elastography" AND liver

Searching the Web

EASL non-invasive liver tests transient elastography FibroScan interpretation kPa CAP official guidelines

Reading File
Reading File
Reading Web Page

https://easl.eu/wp-content/uploads/2021/06/EASL-Clinical-Pra…

Reading File
FibroScan is a painless ultrasound-based test that estimates:
  1. Liver stiffness in kPa: mainly a marker of liver scarring (fibrosis)
  2. CAP score in dB/m, if reported: a marker of liver fat (steatosis)

1. Liver stiffness measurement (kPa)

For many people with fatty liver disease or alcohol-related liver disease, a practical interpretation is:
Liver stiffnessUsual meaning
<8 kPaAdvanced fibrosis is unlikely
8-12 kPaIndeterminate or possible significant fibrosis. Interpret with blood tests and clinical context.
>12-15 kPaAdvanced fibrosis/cirrhosis becomes more likely and specialist review is appropriate
EASL guidance uses approximately <8-10 kPa to rule out compensated advanced chronic liver disease and >12-15 kPa to rule it in. The cutoffs vary by the underlying cause of liver disease, so a single number does not directly equal a specific fibrosis stage such as F0, F1, F2, F3, or F4. FibroScan is strongest at distinguishing cirrhosis from no cirrhosis and is less precise for mild to moderate fibrosis. EASL non-invasive test guideline
Typical causes need different thresholds:
  • Hepatitis B or C: cutoffs can differ, particularly if inflammation is active.
  • MASLD/NAFLD: obesity and metabolic factors can affect accuracy.
  • Alcohol-related liver disease: recent heavy drinking or alcoholic hepatitis can elevate stiffness.
  • Cholestatic, congestive, or autoimmune liver diseases: interpretation should be individualized.

2. CAP score (fat in the liver)

Common approximate CAP categories are:
CAP scoreTypical interpretation
<248 dB/mLittle or no steatosis
248-267 dB/mMild steatosis
268-279 dB/mModerate steatosis
≥280 dB/mSevere steatosis
These thresholds are estimates, not an exact percentage of fat. BMI, diabetes, and the underlying liver condition can shift the best cutoff. EASL guidance on CAP

3. Check whether the result is reliable

Look for these items on the report:
  • Valid measurements: ideally at least 10
  • IQR/median ratio: ideally ≤30% for a reliable stiffness result
  • Probe: M probe is common; XL probe is often used with higher BMI or greater skin-to-liver distance
  • Fasting: a meal can temporarily raise stiffness. Testing is commonly done after fasting for at least 3 hours.
A high stiffness result can reflect scarring, but it can also be temporarily raised by active hepatitis or high ALT, bile-duct obstruction, liver congestion from heart failure, recent alcohol intake, or eating shortly before the test. FibroScan measures stiffness, not fibrosis directly. Sleisenger and Fordtran's Gastrointestinal and Liver Disease explains that the test measures how fast a shear wave passes through liver tissue, since fibrotic tissue is generally stiffer, but accuracy is lower for less advanced fibrosis. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, p. 574.

What to do with your result

Interpret it alongside:
  • AST, ALT, bilirubin, albumin, INR, platelet count
  • FIB-4 score
  • ultrasound findings
  • alcohol use, weight, diabetes, viral hepatitis status, and medications
If the stiffness is ≥8 kPa, liver enzymes or platelets are abnormal, or there are clinical signs of liver disease, discuss it with a gastroenterologist/hepatologist. A result >12-15 kPa usually warrants more prompt specialist assessment, but it does not independently diagnose cirrhosis.
If you share the exact kPa, CAP, IQR/median, probe type, fasting status, and why the scan was ordered, I can help explain what the report suggests.

kpa is 13.5 ,Cap is 314 , IQR is 12.5 percent

Reading File
Finding Sources
Searching PubMed

"transient elastography" AND fatty liver

Searching the Web

EASL 2024 MASLD transient elastography 12 kPa 15 kPa CAP 280 dB m guideline

Your FibroScan appears technically reliable:
  • IQR/median 12.5%: good reliability. A value below 30% is generally acceptable.
  • Liver stiffness 13.5 kPa: this is elevated and falls in a range where advanced fibrosis is likely. Depending on the cause of liver disease, it may be consistent with F3 fibrosis or compensated cirrhosis (F4), but FibroScan alone cannot make that diagnosis.
  • CAP 314 dB/m: indicates marked liver fat, often categorized as severe steatosis (S3 range).
In the context of fatty liver disease, EASL guidance uses transient elastography values above roughly 12-15 kPa to support advanced chronic liver disease, while lower values are more useful for excluding it. See the EASL non-invasive liver-test guidance. The result should be interpreted with blood tests, particularly platelet count, AST, ALT, bilirubin, albumin, and INR, plus ultrasound findings and alcohol history.

What to do next

Please arrange a gastroenterology/hepatology review, preferably soon, for:
  • FIB-4 calculation using age, AST, ALT, and platelets
  • Full liver-function and hepatitis testing if not already done
  • Abdominal ultrasound, and assessment for features of portal hypertension if clinically indicated
  • Review of alcohol intake, diabetes, cholesterol, body weight, and medicines
A stiffness result can be temporarily higher if the scan was done after eating, during active liver inflammation with high ALT/AST, recent heavy alcohol use, bile-duct blockage, or heart-related liver congestion. But your low IQR supports that the measurement itself was consistent. FibroScan measures liver stiffness as a surrogate for scarring and is most accurate for identifying advanced fibrosis/cirrhosis rather than finer distinctions among early stages. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, p. 574.
If you provide your age, AST, ALT, platelet count, bilirubin, albumin, and alcohol use, I can calculate FIB-4 and put this result into clearer context.
This is a shared conversation. Sign in to Orris to start your own chat.